1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Adult T Acute Lymphoblastic Leukemia: new trials by email Literature Review of Adult T Acute Lymphoblastic Leukemia trials Research Report on Adult T Acute Lymphoblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma Bortezomib, Cyclophosphamide, Cytarabine - Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 847 | 2014-10-04 | 2026-10-21 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Bortezomib (1) · Calcium Dobesilate (1) · Cyclophosphamide (1) · Cytarabine (1) · Daunorubicin (1) · Dexamethasone (1) · Doxorubicin (1) · Etoposide (1) · Hydrocortisone (1) · Ifosfamide (1) · Leucovorin (1) · Mercaptopurine (1) · Methotrexate (1) · Radiation (1) · Radiotherapy (1)
National Cancer Institute (NCI) (1)
Australia (1) · Canada (1) · New Zealand (1) · United States (1)
David T Teachey (1)
PMID 35271306, PMID 36603187, PMID 38457359
U10CA098543 (1), U10CA180886 (1)